Happiness Biotech Group Limited logo
Happiness Biotech Group Limited HAPP

Annual report 2022
added 08-16-2022

report update icon

Happiness Biotech Group Limited Net Income 2011-2026 | HAPP

Net profit is a financial indicator that reflects the remaining amount of money after deducting all expenses and taxes from the company’s total income over a certain period of time. It is one of the key indicators of a company’s financial stability and success.

Net profit is the portion of total profit remaining after taxes and depreciation have been deducted.[1]

It is the result of a company’s operations and reflects its efficiency in managing resources, controlling expenses, and generating income. It includes all operating revenues and expenses, such as sales of goods or services, production costs, administrative expenses, taxes, and other financial metrics.

The calculation of net profit includes the deduction of all necessary expenses such as employee salaries, rent, utilities, taxes, and other mandatory payments. After all these expenses are deducted from the total income, the remaining amount is considered the company’s net profit.

Net profit is an important indicator of a company’s financial health, as it reflects its ability to generate earnings and manage its finances. High net profit indicates business success, competitiveness, and efficiency in resource utilization. It also allows a company to invest in its development, pay dividends to shareholders, or create reserve funds for unforeseen situations.

It serves as a basis for calculating other financial indicators, such as return on sales, return on assets, or return on equity. It is also used to assess the performance of management and make decisions regarding the future development of the company.

However, it should be noted that net profit can be affected by various factors, such as economic conditions, changes in legislation, market competition, and other external influences. Therefore, companies must be prepared for possible changes and take measures to ensure the stability of their financial results.

Annual Net Income Happiness Biotech Group Limited

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-49.2 M 786 K 12.7 M 18.7 M 17.5 M 14.5 M - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
18.7 M -49.2 M 2.5 M

References

  1. Bhamornsiri, S., & Wiggins, C. (2001). Comprehensive income disclosures. The CPA Journal, 71(10), 54.

Net Income of other stocks in the Biotechnology industry

Issuer Net Income Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
-514 M - 2.43 % $ 254 M germanyGermany
Ultragenyx Pharmaceutical Ultragenyx Pharmaceutical
RARE
-575 M $ 19.23 -3.85 % $ 1.9 B usaUSA
ARCA biopharma ARCA biopharma
ABIO
-83.7 M - 1052.0 % $ 415 M usaUSA
RedHill Biopharma Ltd. RedHill Biopharma Ltd.
RDHL
-97.7 M $ 0.8 0.89 % $ 428 M israelIsrael
Dr. Reddy's Laboratories Limited Dr. Reddy's Laboratories Limited
RDY
17.2 B $ 13.56 -1.56 % $ 2.25 B indiaIndia
Regeneron Pharmaceuticals Regeneron Pharmaceuticals
REGN
4.5 B $ 742.02 -1.94 % $ 77.6 B usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
-8.37 M - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
-19.2 M - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
-155 M - - $ 1.01 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
-14.7 M - 1.93 % $ 17.4 M usaUSA
Akouos Akouos
AKUS
-86.7 M - 0.23 % $ 488 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
-252 M - - $ 3.67 B usaUSA
I-Mab I-Mab
IMAB
-1.47 B - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
603 M - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
67.3 M - 2.54 % $ 160 B franceFrance
Albireo Pharma Albireo Pharma
ALBO
-34 M - -0.23 % $ 916 M usaUSA
Replimune Group Replimune Group
REPL
-247 M $ 7.22 -4.24 % $ 582 M usaUSA
Biophytis SA Biophytis SA
BPTS
-31.2 M - -13.47 % $ 169 M franceFrance
REGENXBIO REGENXBIO
RGNX
-194 M $ 7.88 -4.6 % $ 406 M usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
-49.9 M - 10.36 % $ 9.8 M usaUSA
Aptinyx Aptinyx
APTX
-64.8 M - -39.0 % $ 4.57 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
-5.46 M - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
-8.09 M - -1.52 % $ 24.7 M usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
-616 M - -6.81 % $ 3.04 B usaUSA
Rigel Pharmaceuticals Rigel Pharmaceuticals
RIGL
367 M $ 26.2 -0.64 % $ 471 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
-18.4 M - - $ 26.5 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
-11.7 M - -52.27 % $ 4.45 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
-38 M - - $ 7.46 M israelIsrael
Atreca Atreca
BCEL
-97.2 M - -11.76 % $ 5.79 M usaUSA
Avidity Biosciences Avidity Biosciences
RNA
-685 M $ 13.09 -0.08 % $ 1.8 B usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
-253 M - -24.86 % $ 820 K usaUSA
bluebird bio bluebird bio
BLUE
-212 M - - $ 546 M usaUSA
Acasti Pharma Acasti Pharma
ACST
-9.57 M - 4.01 % $ 150 M canadaCanada
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
72.9 M - - - russiaRussia
Avid Bioservices Avid Bioservices
CDMO
-141 M - - $ 789 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
-131 M - - $ 86.2 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
-26.2 M - 2.71 % $ 14 M usaUSA
Advaxis Advaxis
ADXS
-48.1 M - -9.65 % $ 45.9 M usaUSA
Rhythm Pharmaceuticals Rhythm Pharmaceuticals
RYTM
-197 M $ 78.52 -4.13 % $ 5.1 B usaUSA
Adaptive Biotechnologies Corporation Adaptive Biotechnologies Corporation
ADPT
-59.5 M $ 12.57 -9.96 % $ 1.91 B usaUSA
Sana Biotechnology Sana Biotechnology
SANA
-244 M $ 2.78 -8.42 % $ 704 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
287 M - 0.49 % $ 251 B cayman-islandsCayman-islands
SIGA Technologies SIGA Technologies
SIGA
23.3 M $ 5.35 7.76 % $ 383 M usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
314 M $ 321.71 -1.96 % $ 42.1 B usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
84.9 M - -4.8 % $ 255 M usaUSA
Cara Therapeutics Cara Therapeutics
CARA
-119 M - -3.03 % $ 260 M usaUSA
ChemoCentryx ChemoCentryx
CCXI
-132 M - - $ 3.74 B usaUSA
Silence Therapeutics plc Silence Therapeutics plc
SLN
-39.4 M $ 4.8 -9.6 % $ 622 M britainBritain
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd.
ENLV
-15 M $ 1.08 -0.92 % $ 22.2 M israelIsrael
Enochian Biosciences Enochian Biosciences
ENOB
-178 M - - $ 40.5 M usaUSA